Molecular mechanisms of SH2- and PTB-Domain-containing proteins in receptor tyrosine kinase signaling

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 12, 2013, Pages

  Wagner, Melany J ^a   Stacey, Melissa M ^a   Liu, Bernard A ^a   Pawson, Tony ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE;

BINDING SITE; CHEMICAL STRUCTURE; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

AMINO ACID MOTIFS; BINDING SITES; HUMANS; MODELS, MOLECULAR; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 84883826376     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a008987     Document Type: Article

References (132)

1. Abella JV, Peschard P, Naujokas MA, Lin T, Saucier C, Urbe S, Park M. 2005. Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol Cell Biol 25: 9632-9645.
2. Ahmed Z, Smith BJ, Kotani K, Wilden P, Pillay TS. 1999. APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase. Biochem J 341: 665-668.
3. Amrein KE, Sefton BM. 1988. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts. Proc Natl Acad Sci 85: 4247-4251.
4. Anderson D, Koch CA, Grey L, Ellis C, Moran MF, Pawson T. 1990. Binding of SH2 domains of phospholipase Cg1, GAP, and Src to activated growth factor receptors. Science 250: 979-982.
5. Araki T, Nawa H, Neel BG. 2003. Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J Biol Chem 278: 41677-41684.
6. Bae JH, Lew ED, Yuzawa S, Tome F, Lax I, Schlessinger J. 2009. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site. Cell 138: 514-524.
7. Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG. 1994. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor b to Ras. Proc Natl Acad Sci 91: 7335-7339.
8. Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, et al. 2004. Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 64: 8816-8820.
9. Bergamin E, Hallock PT, Burden SJ, Hubbard SR. 2010. The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization. Mol Cell 39: 100-109.
10. Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B. 1994. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem 269: 32031-32034.
11. Borg JP, Ooi J, Levy E, Margolis B. 1996. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16: 6229-6241.
12. Cho JH, Muralidharan V, Vila-Perello M, Raleigh DP, Muir TW, Palmer AG 3rd. 2011. Tuning protein autoinhibition by domain destabilization. Nat Struct Mol Biol 18: 550-555.
13. Cooper JA, Gould KL, Cartwright CA, Hunter T. 1986. Tyr527 is phosphorylated in pp60c-src: Implications for regulation. Science 231: 1431-1434.
14. Cunnick JM, Dorsey JF, Munoz-Antonia T, Mei L, Wu J. 2000. Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J Biol Chem 275: 13842-13848.
15. Darnell JE Jr. 1997. STATs and gene regulation. Science 277: 1630-1635.
16. Deb TB, Wong L, Salomon DS, Zhou G, Dixon JE, Gutkind JS, Thompson SA, Johnson GR. 1998. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation. J Biol Chem 273: 16643-16646.
17. Dhe-Paganon S, Werner ED, Nishi M, Hansen L, Chi YI, Shoelson SE. 2004. A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 11: 968-974.
18. Dho SE, Jacob S, Wolting CD, French MB, Rohrschneider LR, McGlade CJ. 1998. The mammalian numb phosphotyrosine-binding domain. Characterization of binding specificity and identification of a novel PDZ domaincontaining numb binding protein, LNX. J Biol Chem 273: 9179-9187.
19. Eck MJ, Pluskey S, Trub T, Harrison SC, Shoelson SE. 1996. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 379: 277-280.
20. Engel AG. 2012. Current status of the congenital myasthenic syndromes. Neuromuscul Disord 22: 99-111.
21. Feller SM, Knudsen B, Hanafusa H. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J 13: 2341-2351.
22. Filippakopoulos P, Kofler M, Hantschel O, Gish GD, Grebien F, Salah E, Neudecker P, Kay LE, Turk BE, SupertiFurga G, et al. 2008. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134: 793-803.
23. Grebien F, Hantschel O, Wojcik J, Kaupe I, Kovacic B, Wyrzucki AM, Gish GD, Cerny-Reiterer S, Koide A, Beug H, et al. 2011. Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell 147: 306-319.
24. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 15: 2500-2508.
25. Guy GR, Yusoff P, Bangarusamy D, Fong CW, Wong ES. 2002. Dockers at the crossroads. Cell Signal 14: 11-20
26. Hantschel O, Nagar B, Guettler S, Kretzschmar J, Dorey K, Kuriyan J, Superti-Furga G. 2003. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112: 845-857.
27. Harrison SC. 1996. Peptide-surface association: The case of PDZ and PTB domains. Cell 86: 341-343.
28. Hatada MH, Lu X, Laird ER, Green J, Morgenstern JP, Lou M, Marr CS, Phillips TB, Ram MK, Theriault K, et al. 1995. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377:32-38.
29. Hidaka M, Homma Y, Takenawa T. 1991. Highly conserved eight amino acid sequence in SH2 is important for recognition of phosphotyrosine site. Biochem Biophys Res Commun 180: 1490-1497.
30. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92: 441-450.
31. Howell BW, Lanier LM, Frank R, Gertler FB, Cooper JA. 1999. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol Cell Biol 19: 5179-5188.
32. Hu J, Hubbard SR. 2005. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. J Biol Chem 280: 18943-18949.
33. Hu J, Hubbard SR. 2006. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS. J Mol Biol 361: 69-79
34. Hu J, Liu J, Ghirlando R, Saltiel AR, Hubbard SR. 2003. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol Cell 12: 1379-1389.
35. Hunter T. 2007. The age of crosstalk: Phosphorylation, ubiquitination, and beyond. Mol Cell 28: 730-738.
36. Hynes NE, Lane HA. 2005. ERBB receptors and cancer: The complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354.
37. Ji QS, Chattopadhyay A, Vecchi M, Carpenter G. 1999. Physiological requirement for both SH2 domains for phospholipase C-g1 function and interaction with plateletderived growth factor receptors. Mol Cell Biol 19: 4961-4970.
38. Kavanaugh WM, Williams LT. 1994. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266: 1862-1865.
39. Kim HK, Kim JW, Zilberstein A, Margolis B, Kim JG, Schlessinger J, Rhee SG. 1991. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-g 1 phosphorylation on tyrosine residues 783 and 1254. Cell 65: 435-441
40. Kmiecik TE, Shalloway D. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49: 65-73
41. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. 2007. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol 14: 503-510.
42. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. 1991. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674.
43. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89: 693-702
44. Kuriyan J, Cowburn D. 1997. Modular peptide recognition domains in eukaryotic signaling. Ann Rev Biophys Biomol Struct 26: 259-288.
45. Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, Shoelson SE, Walsh CT, Neel BG. 1993. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem 268: 21478-21481.
46. Lee JY, Chiu YH, Asara J, Cantley LC. 2011. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85a Src homology-2 domains. Proc Natl Acad Sci 108: 14157-14162.
47. Lerner EC, Smithgall TE. 2002. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nat Struct Biol 9: 365-369.
48. Levy DE, Darnell JE Jr. 2002. Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662
49. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, BarSagi D, Margolis B, Schlessinger J. 1993. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363: 85-88.
50. Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA, Schlessinger J. 1994. A new function for a phosphotyrosine phosphatase: Linking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol 14: 509-517.
51. Li SC, Gish G, Yang D, Coffey AJ, Forman-Kay JD, Ernberg I, Kay LE, Pawson T. 1999. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. Curr Biol 9: 1355-1362.
52. Li W, Young SL, King N, Miller WT. 2008. Signaling properties of a non-metazoan Src kinase and the evolutionary history of Src negative regulation. J Biol Chem 283: 15491-15501.
53. Liu X, Brodeur SR, Gish G, Songyang Z, Cantley LC, Laudano AP, Pawson T. 1993. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene 8: 1119-1126.
54. Liu BA, Jablonowski K, Raina M, Arce M, Pawson T, Nash PD. 2006. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell 22: 851-868.
55. Lu W, Gong D, Bar-Sagi D, Cole PA. 2001. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 8: 759-769.
56. 292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem 272: 33140-33144.
57. Ma CS, Deenick EK. 2011. The role of SAP and SLAM family molecules in the humoral immune response. Ann NY Acad Sci 1217: 32-44.
58. Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell 129: 1261-1274.
59. Marengere LE, Songyang Z, Gish GD, Schaller MD, Parsons JT, Stern MJ, Cantley LC, Pawson T. 1994. SH2 domain specificity and activity modified by a single residue. Nature 369: 502-505.
60. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M, Bar-Sagi D, Kuriyan J. 2003. Structural evidence for feedback activation by Ras.GTP of the Rasspecific nucleotide exchange factor SOS. Cell 112: 685-695.
61. Maroun CR, Naujokas MA, Holgado-Madruga M, Wong AJ, Park M. 2000. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signalregulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 20: 8513-8525.
62. Martin GS. 2001. The hunting of the Src. Nat Rev Mol Cell Biol 2: 467-475.
63. Mayer BJ, Hirai H, Sakai R. 1995. Evidence that SH2 domains promote processive phosphorylation by proteintyrosine kinases. Curr Biol 5: 296-305.
64. Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ. 1999. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398: 84-90
65. Moodie SA, Alleman-Sposeto J, Gustafson TA. 1999. Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274: 11186-11193.
66. Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, Clarkson B, Superti-Furga G, Kuriyan J. 2003. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112: 859-871.
67. Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, Kuriyan J. 2006. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell 21: 787-798.
68. Newton AC. 2009. Lipid activation of protein kinases. J Lipid Res 50: S266-S271.
69. Ng C, Jackson RA, Buschdorf JP, Sun Q, Guy GR, Sivaraman J. 2008. Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates. EMBO J 27: 804-816.
70. Nika K, Tautz L, Arimura Y, Vang T, Williams S, Mustelin T. 2007. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling. J Biol Chem 282: 36000-36009.
71. Nishi M, Werner ED, Oh BC, Frantz JD, Dhe-Paganon S, Hansen L, Lee J, Shoelson SE. 2005. Kinase activation through dimerization by human SH2-B. Mol Cell Biol 25: 2607-2621.
72. Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M. 1994. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol 14: 6674-6682.
73. Ogawa A, Takayama Y, Sakai H, Chong KT, Takeuchi S, Nakagawa A, Nada S, Okada M, Tsukihara T. 2002. Structure of the carboxyl-terminal Src kinase, Csk. J Biol Chem 277: 14351-14354.
74. Okada M, Nakagawa H. 1989. A protein tyrosine kinase involved in regulation of pp60c-src function. J Biol Chem 264: 20886-20893.
75. Okada K, Inoue A, Okada M, Murata Y, Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M, et al. 2006. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312: 1802-1805.
76. O'Reilly AM, Pluskey S, Shoelson SE, Neel BG. 2000. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol Cell Biol 20: 299-311.
77. Ottinger EA, Botfield MC, Shoelson SE. 1998. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J Biol Chem 273: 729-735.
78. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, Vande Woude GF. 1986. Mechanism of met oncogene activation. Cell 45: 895-904.
79. Pawson T. 1995. Protein modules and signalling networks. Nature 373: 573-580.
80. Pawson T, Gish GD, Nash P. 2001. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11: 504-511.
81. Penengo L, Rubin C, Yarden Y, Gaudino G. 2003. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene 22: 3669-3679.
82. Penuel E, Martin GS. 1999. Transformation by v-Src: Ras MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell 10: 1693-1703.
83. Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M. 2001. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 8: 995-1004.
84. Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M. 2004. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem 279: 29565-29571.
85. Pluskey S, Wandless TJ, Walsh CT, Shoelson SE. 1995. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem 270: 2897-2900.
86. Poulin B, Sekiya F, Rhee SG. 2005. Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-g1. Proc Natl Acad Sci 102: 4276-4281.
87. Poy F, Yaffe MB, Sayos J, Saxena K, Morra M, Sumegi J, Cantley LC, Terhorst C, Eck MJ. 1999. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol Cell 4: 555-561.
88. Ramos JW. 2008. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40: 2707-2719.
89. Ravichandran KS. 2001. Signaling via Shc family adapter proteins. Oncogene 20: 6322-6330.
90. Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC. 1995. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol Cell Biol 15: 5725-5731.
91. Rosen MK, Yamazaki T, Gish GD, Kay CM, Pawson T, Kay LE. 1995. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374: 477-479.
92. Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363: 83-85.
93. Ryan PE, Sivadasan-Nair N, Nau MM, Nicholas S, Lipkowitz S. 2010. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitinconjugating enzyme. J Biol Chem 285: 23687-23698
94. Sadowski I, Stone JC, Pawson T. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6: 4396-4408.
95. Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG. 1994. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9: 2827-2836.
96. Sanjay A, Horne WC, Baron R. 2001. The Cbl family: Ubiquitin ligases regulating signaling by tyrosine kinases. Sci STKE 2001: e40.
97. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101
98. Sasaoka T, Kobayashi M. 2000. The functional significance of Shc in insulin signaling as a substrate of the insulin receptor. Endocr J 47: 373-381.
99. Saucier C, Khoury H, Lai KM, Peschard P, Dankort D, Naujokas MA, Holash J, Yancopoulos GD, Muller WJ, Pawson T, et al. 2004. The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proc Natl Acad Sci 101: 2345-2350.
100. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the coreceptor SLAM. Nature 395: 462-469.
101. Schlessinger J, Lemmon MA. 2003. SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003: RE12
102. Schmidt MH, Dikic I. 2005. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6: 907-918
103. Sicheri F, Moarefi I, Kuriyan J. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609
104. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar Sagi D, Kuriyan J. 2004. Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119: 393-405.
105. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778.
106. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349-1353.
107. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, et al. 1998. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphatedependent activation of protein kinase B. Science 279: 710-714.
108. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277: 567-570
109. Stolt PC, Jeon H, Song HK, Herz J, Eck MJ, Blacklow SC. 2003. Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes. Structure 11: 569-579.
110. Stone JC, Atkinson T, Smith M, Pawson T. 1984. Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Cell 37: 549-558.
111. Sugimoto S, Wandless TJ, Shoelson SE, Neel BG, Walsh CT. 1994. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem 269: 13614-13622.
112. Takeuchi S, Takayama Y, Ogawa A, Tamura K, Okada M. 2000. Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk. J Biol Chem 275: 29183-29186.
113. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, et al. 1999. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80.
114. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, et al. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29: 465-468.
115. Uhlik MT, Temple B, Bencharit S, Kimple AJ, Siderovski DP, Johnson GL. 2005. Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol 345: 1-20.
116. van der Geer P, Wiley S, Gish GD, Pawson T. 1996. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr Biol 6: 1435-1444.
117. van der Geer P, Wiley S, Pawson T. 1999. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site. Oncogene 18: 3071-3075
118. Vigna E, Gramaglia D, Longati P, Bardelli A, Comoglio PM. 1999. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPRMET. Oncogene 18: 4275-4281.
119. Vogel W, Ullrich A. 1996. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. Cell Growth Differ 7: 1589-1597
120. Waksman G, Shoelson SE, Pant N, Cowburn D, Kuriyan J. 1993. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72: 779-790.
121. Xu B, Miller WT. 1996. Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain. Mol Cell Biochem 158: 57 - 63
122. Xu W, Harrison SC, Eck MJ. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595-602
123. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC. 1999. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3: 629-638.
124. Yart A, Laffargue M, Mayeux P, Chretien S, Peres C, Tonks N, Roche S, Payrastre B, Chap H, Raynal P. 2001. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J Biol Chem 276: 8856-8864.
125. Yokouchi M, Wakioka T, Sakamoto H, Yasukawa H, Ohtsuka S, Sasaki A, Ohtsubo M, Valius M, Inoue A, Komiya S, et al. 1999. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. Oncogene 18: 759-767.
126. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44.
127. Young MA, Gonfloni S, Superti-Furga G, Roux B, Kuriyan J. 2001. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by Cterminal tyrosine phosphorylation. Cell 105: 115-126
128. Yun M, Keshvara L, Park CG, Zhang YM, Dickerson JB, Zheng J, Rock CO, Curran T, Park HW. 2003. Crystal structures of the Dab homology domains of mouse disabled 1 and 2. J Biol chem 278: 36572-36581.
129. Zhang Z, Lee CH, Mandiyan V, Borg JP, Margolis B, Schlessinger J, Kuriyan J. 1997. Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J 16: 6141-6150.
130. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125: 1137-1149.
131. Zhao ZS, Manser E, Lim L. 2000. Interaction between PAK and nck: A template for Nck targets and role of PAK autophosphorylation. Mol Cell Biol 20: 3906-3917
132. Zhou MM, Ravichandran KS, Olejniczak EF, Petros AM, Meadows RP, Sattler M, Harlan JE, Wade WS, Burakoff SJ, Fesik SW. 1995. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378: 584-592.